Amgen (AMGN) Stock May Be 47% Undervalued After Enbrel Price Cap Ruling

Amgen (AMGN) Stock May Be 47% Undervalued After Enbrel Price Cap Ruling  Yahoo Finance

Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.